Sterilization products maker STERIS (NYSE:STE) is experiencing a more slow and costly transition to a new version of its flagship sterilization system than the company expected.The company had earlier projected between 5,000 and 8,000 sales on the year of its new System 1E, a liquid chemical sterilizing system used by hospitals, surgical [...]

STERIS (NYSE:STE) has obtained 510(k) clearance from the U.S. Food and Drug Administration on two new sterilization devices and one clearance for a minor enhancement on an existing product.Details of the new products were fairly sketchy, as a STERIS spokesman declined to provide much information until after the products are launched at an unspecified time. [...]

Sterilization products company STERIS (NYSE:STE) is looking to hire more than 50 employees at its suburban Cleveland headquarters, with a particular emphasis on engineers.The healthcare jobs hiring binge is part of the company’s plan to add about 300 positions to its Mentor, Ohio headquarters in the coming years. The hires are related to the opening [...]

The top executive with sterilization products maker STERIS (NYSE:STE) said the transition to a replacement version of its flagship sterilization device is “moving along as expected.”The Mentor, Ohio-based company during the most recent quarter shipped 700 units of its new System 1E device, which is a liquid chemical sterilizing system used by hospitals, [...]

The U.S. Food and Drug Administration has given STERIS (NYSE: STE) customers an additional six months to transition from the company’s recalled System 1 sterilization device.Customers have been given until Feb. 2 to make the change to an alternate processing system, according to a regulatory filing from Mentor, Ohio-based STERIS. The company said it would [...]

Sterilization and decontamination technology firm STERIS (NYSE: STE) says construction on a new $11 million, 55,000-square-foot customer solutions center in suburban Cleveland is expected to wrap up in May.

Decontamination technologies maker Steris Corp.’s (NYSE:STE) struggles with the FDA continue, as the federal agency sent the medical device company a warning letter for making improper marketing claims about several steam-sterilization devices.

Infection prevention and decontamination technologies maker Steris Corp.’s (NYSE:STE) third-quarter profits dropped 20 percent as the company struggles to replace lost revenue from its recalled System 1 sterilization device. The company also decreased its projection for full-year revenue, citing lower-than-anticipated shipments of its new System 1E sterilization device, a replacement product for System 1.

Sterilization products maker Steris Corp. (NYSE: STE) is hosting a “virtual career fair” with the hopes of hiring about 100 workers for its Mentor, Ohio, headquarters. Most positions Steris has listed appear to be in customer service, though there are also openings in plenty of other areas — engineering, regulatory affairs, and training and development, for example.

STERIS Corp. (NYSE: STE) has begun shipping the replacement to its System 1 sterilization system, as the company looks to put one of its more difficult periods in its past. The company said shipments of its new System 1E wouldn’t have a material effect on third-quarter financial results, but the shipments are an important step for STERIS, which has spent the last year trying to work its way back from a federal safety alert that said its System 1 device could harm patients.